138 related articles for article (PubMed ID: 1294637)
1. Ki-67 antibody labeling index in colorectal carcinoma.
Suzuki H; Matsumoto K; Terabe M
J Clin Gastroenterol; 1992 Dec; 15(4):317-20. PubMed ID: 1294637
[TBL] [Abstract][Full Text] [Related]
2. Prospective study of Ki-67 labeling index in the mucosa adjacent to cancer as a marker for colorectal cancer metastasis.
Kuniyasu H; Oue N; Shigeishi H; Ito R; Kato Y; Yokozaki H; Yasui W
J Exp Clin Cancer Res; 2001 Dec; 20(4):543-8. PubMed ID: 11876549
[TBL] [Abstract][Full Text] [Related]
3. Ki-67-determined growth fraction versus standard staging and grading parameters in colorectal carcinoma. A multivariate analysis.
Kubota Y; Petras RE; Easley KA; Bauer TW; Tubbs RR; Fazio VW
Cancer; 1992 Dec; 70(11):2602-9. PubMed ID: 1423188
[TBL] [Abstract][Full Text] [Related]
4. Venous invasion and down-regulation of p21(WAF1/CIP1) are associated with metastasis in colorectal carcinomas.
Mitomi H; Mori A; Kanazawa H; Nishiyama Y; Ihara A; Otani Y; Sada M; Kobayashi K; Igarashi M
Hepatogastroenterology; 2005; 52(65):1421-6. PubMed ID: 16201087
[TBL] [Abstract][Full Text] [Related]
5. Heterogeneity of mutant versus wild-type Ki-ras in primary and metastatic colorectal carcinomas, and association of codon-12 valine with early mortality.
Al-Mulla F; Going JJ; Sowden ET; Winter A; Pickford IR; Birnie GD
J Pathol; 1998 Jun; 185(2):130-8. PubMed ID: 9713338
[TBL] [Abstract][Full Text] [Related]
6. Stereologic estimates of volume-weighted mean nuclear volume in colorectal adenocarcinoma: correlation with histologic grading, Dukes' staging, cell proliferation activity and p53 protein expression.
Martín R; Nieto S; Santamaría L
Gen Diagn Pathol; 1997 Jul; 143(1):29-38. PubMed ID: 9269906
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical assessment of proliferative activity in adrenocortical neoplasms.
Goldblum JR; Shannon R; Kaldjian EP; Thiny M; Davenport R; Thompson N; Lloyd RV
Mod Pathol; 1993 Nov; 6(6):663-8. PubMed ID: 7508113
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical assessment of growth fractions in colorectal adenocarcinomas with monoclonal antibody Ki-67. Relation to clinical and pathological variables.
Lanza G; Cavazzini L; Borghi L; Ferretti S; Buccoliero F; Rubbini M
Pathol Res Pract; 1990 Oct; 186(5):608-18. PubMed ID: 2287588
[TBL] [Abstract][Full Text] [Related]
9. Assessment of Ki-67-derived tumor proliferative activity in colorectal adenocarcinomas.
Sahin AA; Ro JY; Brown RW; Ordonez NG; Cleary KR; el-Naggar AK; Wilson P; Ayala AG
Mod Pathol; 1994 Jan; 7(1):17-22. PubMed ID: 8159647
[TBL] [Abstract][Full Text] [Related]
10. Ki-67 proliferating index and histological grade, type and stage of colorectal carcinoma.
Nabi U; Nagi AH; Sami W
J Ayub Med Coll Abbottabad; 2008; 20(4):44-8. PubMed ID: 19999202
[TBL] [Abstract][Full Text] [Related]
11. Detection of lymph nodes micrometastases in Dukes' A and B colorectal cancer using anti-cytokeratin antibodies AE1/AE3.
Zhou ZW; Rieger N; Ruszkiewicz A; Wang GQ; Wan DS
World J Gastroenterol; 2005 Jun; 11(23):3640-3. PubMed ID: 15962393
[TBL] [Abstract][Full Text] [Related]
12. Correlation of bcl-2 oncoprotein immunohistochemical expression with proliferation index and histopathologic parameters in colorectal neoplasia.
Saleh HA; Jackson H; Khatib G; Banerjee M
Pathol Oncol Res; 1999; 5(4):273-9. PubMed ID: 10607921
[TBL] [Abstract][Full Text] [Related]
13. Identification of occult micrometastases in pericolic lymph nodes of Duke's B colorectal cancer patients using monoclonal antibodies against cytokeratin and CC49. Correlation with long-term survival.
Greenson JK; Isenhart CE; Rice R; Mojzisik C; Houchens D; Martin EW
Cancer; 1994 Feb; 73(3):563-9. PubMed ID: 7507795
[TBL] [Abstract][Full Text] [Related]
14. Prognostic markers of colorectal cancer: an evaluation of DNA content, epidermal growth factor receptor, and Ki-67.
Hemming AW; Davis NL; Kluftinger A; Robinson B; Quenville NF; Liseman B; LeRiche J
J Surg Oncol; 1992 Nov; 51(3):147-52. PubMed ID: 1434639
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical expression of bcl-2 in Dukes' stage B and C colorectal carcinoma patients: correlation with p53 and ki-67 in evaluating prognostic significance.
Zavrides H; Zizi-Sermpetzoglou A; Elemenoglou I; Papatheofanis I; Peros G; Athanasas G; Panousopoulos D
Pol J Pathol; 2005; 56(4):179-85. PubMed ID: 16477877
[TBL] [Abstract][Full Text] [Related]
16. Proliferation of invasive breast carcinomas and colorectal adenocarcinomas: an immunohistochemical in situ investigation with the monoclonal antibody Ki-67.
Horny HP; Horst HA
Zentralbl Allg Pathol; 1988; 134(6):547-54. PubMed ID: 3213288
[TBL] [Abstract][Full Text] [Related]
17. Correlation of thymidine phosphorylase staining and the Ki-67 labeling index to clinicopathologic factors and hepatic metastasis in patients with colorectal cancer.
Kitabatake T; Kojima K; Fukasawa M; Beppu T; Futagawa S
Surg Today; 2002; 32(4):322-8. PubMed ID: 12027197
[TBL] [Abstract][Full Text] [Related]
18. Immunocytochemical staining of proliferating cells in endoscopically biopsied tissues of gastric carcinomas with monoclonal antibody Ki-67.
Yonemura Y; Kimura H; Ooyama S; Kamata T; Yamaguchi A; Matsumoto H; Ninomiya I; Miyazaki I
Oncology; 1991; 48(2):162-5. PubMed ID: 1997941
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical detection of proliferating tumor cells in cervical cancer using monoclonal antibody Ki-67.
Wong FW
Gynecol Obstet Invest; 1994; 37(2):123-6. PubMed ID: 8150368
[TBL] [Abstract][Full Text] [Related]
20. Apoptosis and immunohistochemical bcl-2 expression in colorectal adenomas and carcinomas. Aspects of carcinogenesis and prognostic significance.
Baretton GB; Diebold J; Christoforis G; Vogt M; Müller C; Dopfer K; Schneiderbanger K; Schmidt M; Löhrs U
Cancer; 1996 Jan; 77(2):255-64. PubMed ID: 8625232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
